Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Heidi Ackerly
Introduction
Heidi Ackerly is a prominent inventor based in Belmont, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic methods. Her work focuses on the STOP-1 polypeptide, which has implications for treating and preventing various diseases.
Latest Patents
Heidi Ackerly holds 1 patent related to her innovative research. The patent, titled "Compositions and methods relating to STOP-1," provides novel polypeptides, antibodies, antagonists, agonists, potentiators, and nucleic acid molecules. These inventions are useful for medical diagnosis and research, as well as for treating diseases. The patent also includes consensus sequences and specific sequences for antibodies that bind to STOP-1, enhancing the methods described.
Career Highlights
Heidi Ackerly is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her role at Genentech allows her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Heidi has worked alongside notable colleagues such as Avi J Ashkenazi and David A Eberhard. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Heidi Ackerly's contributions to biotechnology, particularly through her patent on STOP-1, demonstrate her commitment to advancing medical science. Her work continues to influence the development of new therapeutic strategies and diagnostic methods.